ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW - Direct Plan

Other Plans and Options
  • 1.79 %Nav, as on 13-08-2025

  • Previous Nav

  • Net Change on 13-08-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option -0.75 7.21 9.45 28.39 22.07 22.69
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 9.45 28.39 22.07 1.04 6,103.96
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 2.91 23.30 19.29 0.89 8,736.57
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 11.51 27.64 21.28 0.91 4,026.55
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 5.29 22.67 20.15 0.48 2,908.21
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 4.88 24.98 20.33 0.61 1,339
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option Dec 28, 2015 4.88 24.98 20.33 0.61 1,339

Fund Holdings as on 31-July-2025

  • Sun Pharmaceutical Industries Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • Aurobindo Pharma Ltd.

  • Lupin Ltd.

  • Mankind Pharma Ltd

  • Alkem Laboratories Ltd.

  • Biocon Ltd.

  • TREPS

  • Gland Pharma Ltd.

  • Zydus Lifesciences Ltd.

  • Syngene International Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Thyrocare Technologies Ltd.

  • Pfizer Ltd.

  • Sagility India Ltd

  • Metropolis Healthcare Ltd.

  • Medplus Health Services Ltd

  • Shilpa Medicare Ltd.

  • Windlas Biotech Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Medi Assist Healthcare Services Ltd

  • Anthem Biosciences Ltd

  • Fine Organic Industries Ltd.

  • Aarti Drugs Ltd.

  • Yatharth Hospital & Trauma Care Services Pvt Ltd

  • J.B.Chemicals & Pharmaceuticals Ltd.

  • Star Health & Allied Insurance

  • Emcure Pharmaceuticals Ltd.

  • Advanced Enzyme Technologies Ltd.

  • FDC Ltd.

  • Sanofi Consumer Healthcare India Ltd

  • Astrazeneca Pharma India Ltd.

  • Procter & Gamble Health Ltd.

  • Senores Pharmaceuticals Ltd

  • Sun Pharma Advanced Research Co. Ltd

  • Net Current Assets

  • Cash Margin - Derivatives

View More

  • Pharmaceuticals & Drugs

  • Business Support

  • Hospital & Healthcare Services

  • Miscellaneous

  • Chemicals

  • Insurance

View More

Most Recent Dividend

  • 08/08/2025

  • 07/08/2024

  • 16/08/2023

  • 12/08/2022

  • 13/08/2021

  • 06/08/2020

  • Cash

  • Equity

View More

About ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund

Scheme Analysis

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹6,103.96 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.46(1.79%)yesterday to ₹26.19.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .

Fund House Contact

One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 2652 5000
enquiry@icicipruamc.com
+91 (22) 2652 8100